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Intravascular Stenting: Indications 
and Complications 
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B=b ’ Maurice Buchbinder, Richard A. Schatz, Yale 
University S&o01 of Medicine, New Haven, CT 
Previous investigators have described the potential 
benefits of intracoronary stentiq. In order to 
adequately assess the role of any new technology it is 
crucial to determine the potential risks of the 
procedure. We report the frequency of major 
conpl ications in 380 patients undergoing attemted 
placanent of the Palmaz-Schatz* intracoronary stent 
and who received courmdin therapy post-implantation. 
In 376 (99%) patients, stents were delivered 
successfully. Of the 380 patients undergoing attempted 
stent placement, there were 3 (0.8%) deaths, occurring 
at 11, 60 and 120 days, 14 coronary throtiotic events 
(1-12 days post-stent) (4%), resulting in 11 instances 
of myocardial infarction or urgent coronary artery 
bypass surgery (7 infarcts, 4 coronary artery bypass 
procedures), 36 of 380 (9%) patiarlts had vascular 
events requiring transfusion or surgery. 
Thus stent delivery was successful in 99% of patients 
but was associated with a major canplication (coronary 
th rorrbotic events, vascular events requiring 
transfusion or surgical repair, or death) in 53 (14%) 
patients. Improvement in the delivery system design 
and in patient selection may impact upon these 
complications. 
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F&-Z! OF LESION-RELATBD SIDE BRANCHES FOLLOWING 
CORONA“y ARTERY STINTING 
F’ACC, Stsven Ellis, MD, FACC, Don Bdm, MD, FtWX, Alex A: 
slaistie, m, Alex slldmvidr, MD, Scripps clinic and 
~&ssaM -tic& La Jolla, CA, U.S.A. 
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Teirstein, M.D., F.A.C.C., Craig Walker, M.D., F.A.C.C., Stephen 
Bailey, M.D., F.A.C.C., Martin Leon, M.D., F.A.C.C., Richard 
Schak, M.D., F.A.C.C., Stephen Ellis, M.D., F.A.C.C., Sheldon 
Goldberg, M.D., F.A.C.C. Thomas Jefferson University Hospital, 
Philadelphia, PA. 
-proesduxa- Rowever, 11 pts (3.4%) had a subaark 
thmabcrticeverrt occudrg l-12 days post plmndlm. 
suba~-isaaxvred afterhfspi~~in 
7 p&l (2.2%) and resulted in lIlymMa infarction (MI) 
in 6 pts (1.9%). Pts with subacubthm&usisoPtenhada 
period of sukptimal antiwatiwr. 
As of 7/3l/90, 201 of the above pts were eligible for 
follcwp and 162 (81%) actually had - WiograplY 
(at mmn = 7.1 Isxkhs). l?estmais (>50% stenasis) was 
- in 37 (23%) of pts ur&qoing argographic 
followup. me 3nflw of prwirxrs resbrmis following 
balloon axgiaplasty was M by dividing p& into 
DE mm, r&o, an?3 previous restem& (Pm’ Rs), n=lU 
gzwps. DENUVOaM~~ptswerresixoila~withrespect 
to baseline clinical and angiwc dlzt?sic!!istics. 
xb6temeis was 34/1l2 (30%) for EREV RS pts, but only 3/50 
110 prior 
of -isafter 
-ins* Howsver, this -lent six & benefit mLlst 
be WleWed agdrtst the peripmceabrral risks. while 
procedural ccqlicatims are rare, psripru&xal ~~BXP 
botic events OQCUI: in 3.4% of pts and on result in Kt, 
often after hospital tikbuge. Strict m to anti- 
Waticm regimenmy raduos thsse thrcms#tic m. 
The aim of this study was to assess the effect of intracoronary 
stenting on the acute and long term patency of lesion associated 
side branches. Serial coronary angiography was performed in 108 
patients (122 lesions) before percutaneous transluminal coronary 
angioplasty WTCA), following conventional PTCA, immediately 
after Palmaz-Schak stent placement, and at 6 months. Of the 122 
lesions, there were 50 side branches with vessel diameters of 2 1 
1 mm whose ostia were bridged by the stent. Eighteen 06%) of 
these side branches had ostial stenoses 250% pre-PITA. Four side 
bra.nzhesbecameoccludedfollowingstandardballoonangioplasty, 
and these remained occluded following stenting. Of the side 
branches patent post-PTCA, 45 of 46 (98%) remained patent 
immediately following stenting and all were patent’at 6 month 
follow-up. One side branch became occluded acutely following 
stenting, but, was patent at 6 month follow-up. Thus all 46 side 
branches patent pre-stenting were patent at 6 mont:ls. In conclu- 
sion, 1) The incidence of acute side branch occlusion due to 
coronary artery stenting is low; 2) Patency of side branch ostia is 
well maintained at 6 months after stenting. 
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CORONARY 
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Pekr N. Ver Lee, David WM. Muller, Jeffrey j. Popma, Stephen 6. 
Ellis, Eric J. Topol, University of Michigan, Ann Arbor, Ml 
Intracoronary stenting in the setting of abrupt closure might be 
expected to carry a higher rate of peri-procedural complications than 
elective stenting due to the associated coronary artery dissection, 
protracted myocardiil ischemia and lack of adequate pm-treatment 
(e.g. dextran). We studied 70 patients who received a total of 82 stents 
(60 Palmaz-Schatz and 22 Gianturco-Roubin stents); 16 were inserted 
for abrupt or threatened abrupt closure (AC) and 54 electively for 
refractory restenosis (El. The two groups were similar with respect to 
mr‘an age (ACX9, E=58 yrs), % males fAC=69, E=831 and anatomic 
location and extent of coronary artery disease. Clinical outcomes and 
quantitative angiography (determined by digital computerized edge 
detection) were as follows: 
success 
Subsequent closure 
Recath for ? lschemia 
Bleeding (any) 
Transfused 
AC H 
(N-16) (N=W 
109% 93% 
6% 7% 
19% 22% 
50% 39% 
31% 15% 
Min lumen diam (mm1 
Pre-stent fmean?SD) 
Post-stent fmeanLSD1 
0.67~0.5 0.94~0.5 
2.4520.5 2.64~0.6 
In conclusion, despite arterial disruption and the urgency of the 
situation, stenting for AC was similar to elective stenting with respect 
to technical results, bleeding, ischemic complications and improvement 
in quantitative arterial dimension. Thus, complications which develop 
after coronary stenting appear to be more closely associated with the 
intervention per se rather than the patienYs clinical status. 
